Monoclonal Rabbit anti‑Mouse AGT / Angiotensinogen Antibody (clone 001, Preservative Free, WB) LS‑C820682
Monoclonal Rabbit anti‑Mouse AGT / Angiotensinogen Antibody (clone 001, Preservative Free, WB) LS‑C820682
Antibody:
AGT / Angiotensinogen Rabbit anti-Mouse Monoclonal (Preservative Free) (001) Antibody
Format:
Unconjugated, Preservative Free
Overview
Antibody:
AGT / Angiotensinogen Rabbit anti-Mouse Monoclonal (Preservative Free) (001) Antibody
Format:
Unconjugated, Preservative Free
Specifications
Description
Angiotensinogen antibody LS-C820682 is an unconjugated rabbit monoclonal antibody to mouse Angiotensinogen (AGT). Validated for WB.
Target
Mouse AGT / Angiotensinogen
Synonyms
AGT | ANHU | Angiotensinogen | Pre-angiotensinogen | SERPINA8 | Serpin A8
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A purified
Modifications
Preservative Free
Immunogen
Recombinant Mouse Angiotensinogen/AGT Protein
Specificity
Mouse Angiotensinogen
Applications
- Western blot (1:1000 - 1:5000)
Usage
Applications should be user optimized.
Presentation
0.2 µm filtered solution in PBS
Storage
Store at 2°C to 8°C for up to 1 month. Aliquot and store at -20°C to -80°C for up to 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About AGT / Angiotensinogen
Featured Products
Species:
Human, Monkey
Applications:
IHC, IHC - Paraffin
Species:
Human, Monkey
Applications:
IHC, IHC - Paraffin
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, ICC, Western blot, Immunoprecipitation, Flow Cytometry
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024